VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,120,782 | -11.2% | 264,614 | -0.6% | 4.67% | -6.2% |
| Q2 2023 | $8,016,137 | -7.0% | 266,228 | -0.1% | 4.98% | -8.6% |
| Q1 2023 | $8,617,155 | +28.6% | 266,372 | +13.9% | 5.44% | +28.4% |
| Q4 2022 | $6,701,510 | -8.7% | 233,828 | -23.2% | 4.24% | +62.1% |
| Q3 2022 | $7,342,000 | +1442.4% | 304,378 | +1649.1% | 2.62% | +669.7% |
| Q2 2022 | $476,000 | +38.4% | 17,402 | +94.2% | 0.34% | +55.3% |
| Q1 2022 | $344,000 | – | 8,962 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |